• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    FMC Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    6/23/26 7:36:05 AM ET
    $FMC
    Major Chemicals
    Industrials
    Get the next $FMC alert in real time by email
    fmc-20260618
    0000037785FALSE00000377852026-06-182026-06-18

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    _______________________________________________________________________
     FORM 8-K
    _______________________________________________________________________
    CURRENT REPORT
    Pursuant to Section 13 or 15 (d) of the
    Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported) June 18, 2026
    __________________________________________________________________________
    FMC CORPORATION
    (Exact name of registrant as specified in its charter)
    __________________________________________________________________________ 
    Delaware1-237694-0479804
    (State or other jurisdiction of
    incorporation or organization)
    (Commission File Number)(I.R.S. Employer
    Identification No.)
    2929 Walnut StreetPhiladelphiaPennsylvania19104
    (Address of Principal Executive Offices)(Zip Code)

    Registrant’s telephone number, including area code: 215-299-6000
    __________________________________________________________________________


    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading SymbolName of each exchange on which registered
    Common Stock, par value $0.10 per shareFMCNew York Stock Exchange

    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act


    Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13 (a) of the Exchange Act.
    ☐




    ITEM 1.01    ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
    On June 18, 2026, FMC Corporation ("FMC") entered into a framework agreement (the "Agreement") to sell its property in Newark, Delaware to Ercor Elkton, LLC for gross cash proceeds of approximately $114 million, subject to a due diligence period and other closing conditions and adjustments. The proposed transaction involves the sale of underutilized buildings and land on the Delaware portion of FMC's campus at the Stine Research Center. The parties intend to negotiate in good faith a form of lease agreement for FMC to leaseback the facilities we actively operate from Ercor Elkton, LLC.
    The transaction is structured to minimize any disruption to our research operations and our Stine Research Center will continue to operate at the site following the transaction. Core research activities and scientific infrastructure remain fully in place, and we do not expect any impact to our research and development capabilities. We will retain ownership of the adjacent Maryland property. The transaction is expected to close in the fourth quarter, subject to a due diligence period and other closing conditions and adjustments, and the proceeds are expected to be used to pay down debt. As is customary for transactions of this kind, the parties may elect to renegotiate certain terms during the diligence period and to amend the framework agreement accordingly. The Agreement also contemplates that the form of the leaseback agreement and various other operational and economic terms are still to be agreed between the parties and are therefore at a preliminary stage. As a result, there can be no assurance that the Agreement will ultimately result in any transaction.
    The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by reference to the Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.
    Statement under the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995:
    This Current Report on Form 8-K contains statements that are “forward-looking” and provide other than historical information, including statements regarding the Agreement, the ability to negotiate a leaseback agreement, any impact on FMC's research operations, and the expected timing of and proceeds from the transaction.
    In some cases, FMC has identified these forward-looking statements by such words or phrases as “outlook,” “will likely result,” “is confident that,” “expect,” “expects,” “should,” “could,” “may,” “will continue to,” “believe,” “believes,” “anticipates,” “predicts,” “forecasts,” “estimates,” “projects,” “potential,” “intends” or similar expressions identifying “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including the negative of those words or phrases. Such forward-looking statements are based on our current views and assumptions regarding future events, future business conditions and the outlook for the company based on currently available information. The forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any results, levels of activity, performance or achievements expressed or implied by any forward-looking statement. These statements are qualified by reference to the risk factors included in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10-K”), the section captioned “Forward-Looking Information” in Part II of the 2025 Form 10-K and to similar risk factors and cautionary statements in all other reports and forms filed with the SEC. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. Forward-looking statements are qualified in their entirety by the above cautionary statement.
    ITEM 9.01.     FINANCIAL STATEMENTS AND EXHIBITS
    (d)     Exhibits
    10.1    Real Estate Purchase and Sale Agreement Between FMC Corporation and Encor Elkton, LLC




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
    FMC CORPORATION
    (Registrant)
    By:/s/ ANDREW D. SANDIFER
    Andrew D. Sandifer
    Executive Vice President and Chief Financial Officer
    Date: June 23, 2026


    Get the next $FMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FMC

    DatePrice TargetRatingAnalyst
    4/22/2026$14.00Hold → Sell
    Vertical Research
    12/9/2025$13.00Equal Weight → Underweight
    Barclays
    11/11/2025$16.00Equal Weight
    Wells Fargo
    10/31/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    10/31/2025$16.00Overweight → Equal Weight
    Wells Fargo
    10/30/2025$22.00Overweight → Equal Weight
    Barclays
    10/14/2025$33.00Underperform → Neutral
    BofA Securities
    6/23/2025$50.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $FMC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    FMC Corp downgraded by Vertical Research with a new price target

    Vertical Research downgraded FMC Corp from Hold to Sell and set a new price target of $14.00

    4/22/26 7:34:40 AM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corp downgraded by Barclays with a new price target

    Barclays downgraded FMC Corp from Equal Weight to Underweight and set a new price target of $13.00

    12/9/25 8:38:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    Wells Fargo resumed coverage on FMC Corp with a new price target

    Wells Fargo resumed coverage of FMC Corp with a rating of Equal Weight and set a new price target of $16.00

    11/11/25 8:04:56 AM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FMC Corporation Announces $114 Million Sale-Leaseback of Newark, Delaware Property

    Company will continue to operate its global R&D headquarters at the Stine Research CenterPHILADELPHIA, June 23, 2026 /PRNewswire/ --FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, today announced that it has entered into a framework agreement to sell its property in Newark, Delaware for gross proceeds of approximately $114 million USD, subject to a due diligence period and other closing conditions and adjustments. Upon completion of the sale, FMC intends to lease back the facilities it actively operates under a separate lease agreement. FMC will retain ownership of its adjacent Maryland properties.The decision to pursue this transaction reflects FMC's ongoing effo

    6/23/26 7:30:00 AM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call

    PHILADELPHIA, June 22, 2026 /PRNewswire/ --FMC Corporation (NYSE:FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com.The company will host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET that is open to the public via internet broadcast and telephone.Conference Call Details:Internet broadcast: https://investors.fmc.comUnited States (Local): +1 585 542 9983United States (Toll-Free): +1 833 461 5787 Global Dial-In Numbers:  Global Dial-in NumberAccess Code: 204774808Pre-Registration Link: https://events.q4inc.com/analyst/204774808

    6/22/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology

    Strategic supply and license agreement will accelerate access for North and South American corn and soybean growersPHILADELPHIA and INDIANAPOLIS, June 16, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) and Corteva, Inc. (NYSE:CTVA), two leading global agricultural science and innovation companies, today announced a co-exclusive strategic supply and license agreement that will expand access to FMC's rimisoxafen technology across North and South America corn and soybean markets, adding an important new tool to each company's respective herbicide portfolio. This collaboration will enable more growers across the Americas to control herbicide-resistant weeds, including Amaranthus species – the n

    6/16/26 5:00:00 PM ET
    $CTVA
    $FMC
    Farming/Seeds/Milling
    Consumer Staples
    Major Chemicals
    Industrials

    $FMC
    SEC Filings

    View All

    FMC Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - FMC CORP (0000037785) (Filer)

    6/23/26 4:01:59 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - FMC CORP (0000037785) (Filer)

    6/23/26 7:36:05 AM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - FMC CORP (0000037785) (Filer)

    6/5/26 4:05:40 PM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barry Michael F bought $249,938 worth of shares (18,072 units at $13.83), increasing direct ownership by 1,157% to 19,634 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    3/5/26 12:11:06 PM ET
    $FMC
    Major Chemicals
    Industrials

    Director Raines John Mitchell bought $96,390 worth of shares (7,000 units at $13.77), increasing direct ownership by 103% to 13,784 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/14/25 9:19:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    Director Davidson Carol Anthony bought $135,957 worth of shares (10,000 units at $13.60), increasing direct ownership by 76% to 23,227 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    11/7/25 8:36:59 AM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, CEO and President Brondeau Pierre R covered exercise/tax liability with 34,177 shares, decreasing direct ownership by 6% to 533,869 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    6/15/26 4:14:59 PM ET
    $FMC
    Major Chemicals
    Industrials

    Director Verduin Patricia was granted 9,175 shares, increasing direct ownership by 128% to 16,326 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    4/30/26 4:23:39 PM ET
    $FMC
    Major Chemicals
    Industrials

    Director Raines John Mitchell was granted 9,175 shares, increasing direct ownership by 66% to 22,996 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    4/30/26 4:22:28 PM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Leadership Updates

    Live Leadership Updates

    View All

    FMC Corporation Announces Election of Michael F. Barry to Board of Directors

    PHILADELPHIA, Feb. 27, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, today announced the election of Michael F. Barry to the company's Board of Directors, effective February 27, 2026. He will serve on the Audit and Compensation and Human Capital committees.Barry brings more than three decades of global leadership experience in the specialty chemicals industry to FMC's Board. He currently serves as chairman of the Board of Directors of Quaker Houghton and previously served as chief executive officer and president of Quaker Houghton until his retirement in November 2021."We are pleased to welcome Michael to the FMC Board of Directors," said Pi

    2/27/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation sets 2026 priorities and announces exploration of strategic options including but not limited to the sale of the company

    Company reports 2025 fourth quarter and full year results, provides 2026 outlook  The organization continues to focus on its 2026 operational priorities, including strengthening the balance sheet, improving the competitiveness of its core portfolio, managing its post-patent Rynaxypyr® active strategy and supporting growth of new active ingredientsThe FMC Board of Directors has authorized the exploration of strategic options, including but not limited to, the sale of the company to unlock shareholder value and ensure its growth and core portfolios are best positioned for long-term success PHILADELPHIA, Feb. 4, 2026 /PRNewswire/ -- FMC Corporation (NYSE: FMC) today announced its 2026 prioritie

    2/4/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation Reports Third Quarter Results

    Company reports Adjusted EBITDA and Adjusted EPS above guidance midpoints despite lower-than-expected sales Third Quarter 2025 Highlights Revenue of $542 million, down 49 percent versus Q3 2024, impacted by significant one-time commercial actions taken in India to position the business for saleRevenue excluding India of $961 million, down 10 percent versus Q3 2024 (which included India); organic revenue for the period declined 11 percentConsolidated GAAP net loss of $569 million, a decline of $634 million versus Q3 2024, mainly driven by India charges and write-downAdjusted EBITDA of $236 million, up 17 percent versus Q3 2024 (which included India)Consolidated GAAP net loss of $4.52 per dilu

    10/29/25 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Financials

    Live finance-specific insights

    View All

    FMC Corporation announces date for second quarter 2026 earnings release and webcast conference call

    PHILADELPHIA, June 22, 2026 /PRNewswire/ --FMC Corporation (NYSE:FMC) announced today it will release its second quarter 2026 earnings on Wednesday, July 29, 2026, after the stock market close via PR Newswire and the company's website https://investors.fmc.com.The company will host a webcast conference call on Thursday, July 30, 2026, at 9:00 a.m. ET that is open to the public via internet broadcast and telephone.Conference Call Details:Internet broadcast: https://investors.fmc.comUnited States (Local): +1 585 542 9983United States (Toll-Free): +1 833 461 5787 Global Dial-In Numbers:  Global Dial-in NumberAccess Code: 204774808Pre-Registration Link: https://events.q4inc.com/analyst/204774808

    6/22/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation reports first quarter 2026 results above guidance with Adjusted EBITDA above high end of range, reaffirms full-year outlook

    Company continues to advance operational priorities and explore strategic options in parallelFirst Quarter 2026 HighlightsRevenue of $759 million, down 4 percent versus Q1 2025Revenue excluding India1 of $762 million, down 4 percent versus Q1 2025 (which included India)Organic revenue2 for the period declined 9 percentConsolidated GAAP net loss of $281 million, a decline of $266 million versus Q1 2025Adjusted EBITDA of $72 million, down 40 percent versus Q1 2025Consolidated GAAP loss of $2.25 per diluted share, down $2.13 versus Q1 2025Adjusted loss per diluted share of $0.23, down 41 cents versus Q1 2025Maintains 2026 Full-Year Outlook1Revenue excluding India of $3.60 billion to $3.80 billi

    4/29/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    FMC Corporation Declares Quarterly Dividend

    PHILADELPHIA, April 28, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on July 16, 2026, to shareholders of record as of the close of business on June 30, 2026.   About FMCFMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protecti

    4/28/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    $FMC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FMC Corporation

    SC 13G/A - FMC CORP (0000037785) (Subject)

    11/8/24 10:46:38 AM ET
    $FMC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by FMC Corporation (Amendment)

    SC 13G/A - FMC CORP (0000037785) (Subject)

    2/13/24 5:04:36 PM ET
    $FMC
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by FMC Corporation (Amendment)

    SC 13G/A - FMC CORP (0000037785) (Subject)

    1/10/24 9:08:13 AM ET
    $FMC
    Major Chemicals
    Industrials